Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring perspectives from Dr Rachel N Grisham, including the following topics: Mechanism, clinical evidence and practical use of avutometinib with defactinib for recurrent low-grade serous ovarian cancer (LGSOC) (0:00) A Phase III trial of letrozole alone as front-line treatment for LGSOC (11:11) Current and future role of avutometinib with defactinib for LGSOC (19:23) A Phase II/III trial of trametinib for recurrent LGSOC: Biomarker analyses and clinical implications (21:37) CME information and select publications

Episode metadata supplied by the publisher feed · Published Sep 13, 2026

Embed this episode

Attribution link and audio player

Ready to play

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

0:00 28:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 28 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on September 13, 2026.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!